Dharini Shah

Company: Sanofi

Job title: Senior Director - Research & Immunology

Seminars:

Targeted mRNA for in vivo Reprogrammed Off-the-Shelf CAR-T Therapies 2:10 pm

Autologous CAR T cell products have been transformational in hematological malignancies; however, manufacturing complexities limit patient access Sanofi’s (Tidal) novel platform offers potential and promise of in vivo delivery of CARencoding mRNA as a novel therapeutics Transforming CAR-therapies by active in vivo reprogramming using novel targeted delivery approaches and advanced RNA therapeuticRead more

day: Conference Day One

Fireside Chat: Bridging the Gap Between Pharma, Biotech & Investors to Support the Development of Upcoming Next Generation RNA Innovations 9:00 am

This discussion-based session will unite specialists from the investment, pharma, and biotech sectors to facilitate the growth and development of the field. Hear investors’ perspectives on evaluating investment opportunities and allocating resources strategically as these stakeholders assess opportunities to invest and collaborate to drive translation of these innovative therapies to benefit patients and improve treatment…Read more

day: Conference Day One